Improvement of postischemic contractile dysfunction of dog heart by MC1-154, a novel cardiotonic agent
| Autor: | Akihiro Narimatsu, Yuji Abe, Akihiro Tobe, Yoshimi Kitada |
|---|---|
| Rok vydání: | 1991 |
| Předmět: |
Pharmacology
medicine.medical_specialty biology business.industry Fissipedia Ischemia Cardiotonic Agents Anterior Descending Coronary Artery medicine.disease biology.organism_classification Contractility Internal medicine Anesthesia Aortic pressure medicine Cardiology Milrinone Dobutamine business medicine.drug |
| Zdroj: | European Journal of Pharmacology. 192:279-285 |
| ISSN: | 0014-2999 |
| Popis: | The effects of MC1-154, a cardiotonic agent which has direct effects on cardiac myofilaments, on postischemic contractile dysfunction were studied in dog heart subjected to a 30-min occlusion of the left anterior descending coronary artery followed by reperfusion, and compared with the effects of milrinone and dobutamine, that have largely cyclic AMP-dependent mechanisms of action. Regional myocardial contractility (segment shortening) and tissue ATP levels were severely depressed in reperfused myocardium. MCI-154 (0.3 and 1 μg/kg per min) improved the regional function of postischemic myocardium and decreased left ventricular end-diastolic pressure and systemic aortic pressure when infused i.v. from 30 min after reperfusion. The improvement of regional function caused by MCI-154 (1 μg/kg per min) was more pronounced than that caused by milrinone (1 μg/kg per min) or dobutamine (1 μg/kg per min), although the drugs produced an equal increase in cardiac performance (peak positive left ventricular dP/dt). These results suggest that MCI-154 produces a more pronounced improvement of regional myocardial function than milrinone and dobutamine, presumably by increasing the responses of the contractile protein system to Ca2+. In this respect, MCI-154 would be of much benefit for the treatment of postischemic left ventricular dysfunction. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|